After standard care, standardized care, and personalized care, network care will be care 4.0. The second day of the New Frontiers symposium, on 2 November 2018, dealt with the complexities of network care. About 250 healthcare stakeholders (professionals, policy makers, insurers, patients) and healthcare researchers attended the symposium.The symposium was chaired by Gert Westert and Jan Kremer. The complete program can be found here.
No easy answers at this conference, only challenges that can be overcome if we succeed in 5 things. First and most radically, put patients in the center of healthcare. Second, start with assessing what the local population needs and not what local professionals have to offer. Third, stop with competition in the healthcare market and find (together with payers) ways to build networks around patients. Fourth, defragment healthcare by regionalizing supply of care. Finally, collaborate and adapt systems to what patients need. Remember, small steps can make huge differences.
Here you can view all the pictures (made by Rob Gieling).
Every year, RIMLS and RIHS each organize an international symposium across one of the thematic areas of the Radboudumc with the intention of exploring the newest scientific research and pioneering developments from molecule to man and population. Here you can find more information about the past symposia.
Related news items
Step-up approach vs open necrosectomy for necrotizing pancreatitis18 April 2019
Another publication of the successful Dutch collaborative group on pancreatitis research with substantial contribution from Radboudumc researchers, Harry van Goor and Kees van Laarhoven.read more
Prophylactic antibiotics reduce hospitalisations and cost in head and neck cancer patients18 April 2019
In European journal of cancer Janneke Ham and colleagues showed that prophylactic antibiotics in locally advanced head and neck cancer patients treated with chemoradiotherapy did not reduce the incidence of (aspiration) pneumonias, but did reduce hospitalisations and tended to be cost-effective.read more
Nontuberculous mycobacteria and fungal co-infections Bonnie and Clyde?18 April 2019
In The European respiratory journal Jakko van Ingen and Sanne Zweijpfenning showed that 40% of patients diagnosed with nontuberculous mycobacterial pulmonary disease also meet diagnostic criteria for chronic pulmonary aspergillosis.read more
ESCMID award for groundbreaking studies on NTM disease18 April 2019
Jakko van Ingen received the ESCMID Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease.read more
EU funded project BIOMAP led by Ellen van den Bogaard12 April 2019
Ellen van den Bogaard, theme Inflammatory diseases, leads the research on the experimental validation and functional analysis of identified biomarkers by using advanced organotypic skin models and receives a grant of €258,000.read more